<DOC>
	<DOC>NCT00322686</DOC>
	<brief_summary>The purpose of this study is to determine whether oglemilast is safe and effective in the treatment of allergen-induced asthma.</brief_summary>
	<brief_title>Study of Oglemilast for the Treatment of Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Mild atopic asthma Hyperreactivity to methacholine Exhibit positive response to standard allergen skin prick test Pulmonary disease other than asthma Asthma exacerbation within 4 weeks History of substance abuse Active cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>oglemilast</keyword>
	<keyword>asthma</keyword>
	<keyword>allergen</keyword>
	<keyword>prevention</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>Allergen-Induced Asthma</keyword>
</DOC>